The association between the polymorphism of RAR related orphan receptor beta and the clinical manifestations of oral squamous cell carcinoma
- PMID: 39744492
- PMCID: PMC11685680
- DOI: 10.7150/jca.103945
The association between the polymorphism of RAR related orphan receptor beta and the clinical manifestations of oral squamous cell carcinoma
Abstract
Oral squamous cell carcinoma (OSCC) affects a substantial proportion of the Asian population and is influenced by various genetic risk factors. The RAR-related orphan receptor beta (RORB), a regulator of the circadian rhythm, has been implicated in certain neoplasms. Accordingly, this study investigated the association between RORB single-nucleotide polymorphisms and clinical manifestations of OSCC. A total of 1174 male patients without OSCC and 1254 male patients with OSCC were included in the study. Three RORB single-nucleotide polymorphism loci-rs3750420 (T/C), rs10781247 (A/G), and rs17611535 (C/T)-were genotyped using TaqMan allelic discrimination assays. RORB single-nucleotide polymorphism rs10781247 variants were significantly associated with moderate to poor cellular differentiation in patients with OSCC (p = 0.042). Additionally, among betel quid chewers with OSCC, rs10781247 variants were significantly associated with moderate to poor cell differentiation (p = 0.036). The rs3750420 variants were significantly associated with larger tumor size in individuals with buccal mucosa cancer (p = 0.036). An analysis of Cancer Genome Atlas data revealed that RORB mRNA levels were significantly higher in patients with head and neck squamous cell carcinoma compared with controls (p = 0.0002). Moreover, RORB mRNA levels were significantly higher in stage IV tumors than in stage III tumors (p = 0.0252). In conclusion, RORB single-nucleotide polymorphisms rs3750420 and rs10781247 are associated with adverse clinical characteristics in OSCC.
Keywords: RAR related orphan receptor beta; betel quid chewing; buccal mucosa cancer; oral cancer; oral squamous cell carcinoma; single nucleotide polymorphism.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Potential impact of ADAM-10 genetic variants with the clinical features of oral squamous cell carcinoma.J Cell Mol Med. 2023 Apr;27(8):1144-1152. doi: 10.1111/jcmm.17728. Epub 2023 Mar 22. J Cell Mol Med. 2023. PMID: 36946281 Free PMC article.
-
Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma.Aging (Albany NY). 2022 May 19;14(10):4500-4512. doi: 10.18632/aging.204089. Epub 2022 May 19. Aging (Albany NY). 2022. PMID: 35587368 Free PMC article.
-
Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma.Front Oncol. 2021 Jun 29;11:684941. doi: 10.3389/fonc.2021.684941. eCollection 2021. Front Oncol. 2021. PMID: 34268119 Free PMC article.
-
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.Health Sci Rep. 2025 Apr 18;8(4):e70650. doi: 10.1002/hsr2.70650. eCollection 2025 Apr. Health Sci Rep. 2025. PMID: 40256126 Free PMC article. Review.
-
Chinese Expert Consensus on Management of Betel-Chewing-Related Oral Squamous Cell Carcinoma.Oral Dis. 2025 Jun 2. doi: 10.1111/odi.15397. Online ahead of print. Oral Dis. 2025. PMID: 40457710 Review.
References
-
- Lu HJ, Su CW, Su SC, Chang LC, Wu MF, Lin CW, Prognostic impact of caspase-8 mutation in oral cavity squamous cell carcinoma. Oral Dis. 2024. Sep 17. Online ahead of print. - PubMed
-
- Howard A, Agrawal N, Gooi Z. Lip and Oral Cavity Squamous Cell Carcinoma. Hematol Oncol Clin North Am. 2021;35:895–911. - PubMed
-
- Su SC, Chang LC, Lin CW, Chen MK, Yu CP, Chung WH. et al. Mutational signatures and mutagenic impacts associated with betel quid chewing in oral squamous cell carcinoma. Hum Genet. 2019;138:1379–89. - PubMed
-
- Su SC, Yeh CM, Lin CW, Hsieh YH, Chuang CY, Tang CH. et al. A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J Pineal Res. 2021;71:e12760. - PubMed
LinkOut - more resources
Full Text Sources